ResearcherEssen University HospitalNo recent work listed

Heike Richly

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6081-0978; OpenAlex author ID A5045084441. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper

Papers 1

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European… Last author DOI 10.1016/j.ejca.2014.10.010 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Max Ernst Scheulen · 1 shared paper, 2015 · strength 0.04
- Paper A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cance… DOI 10.1016/j.ejca.2014.10.010 ↗
Lothar Bergmann · 1 shared paper, 2015 · strength 0.04
- Paper A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cance… DOI 10.1016/j.ejca.2014.10.010 ↗
Bernhard Josef Wormann · 1 shared paper, 2015 · strength 0.04
- Paper A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cance… DOI 10.1016/j.ejca.2014.10.010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.